ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Kidson C, Singhasivanon P, Supavej S, 1999. Mekong Malaria. Southeast Asian J Trop Med Public Health 30 (suppl 4):28–40.
-
2
Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ, 1991. Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 85 :424–429.
-
3
Nosten F, McGready R, Simpson J, Thwai KL, Balkan S, Cho L, Hkirijareon L, Looareesuwan S, White NJ, 1999. Effects of Plasmodium vivax malaria in pregnanacy. Lancet 14 :546–549.
-
4
Schuurkamp G, Spicer PE, Kereu RK, Bulungol PK, 1992. Chloroquine resistant P. vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86 :121–122.
-
5
Baird JK, Basri, Purnomo, Bang MJ, Subbianto B, Patchen LC, Hoffmann SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44 :547–555.
-
6
Soto J, Toledo J, Gutierrz P, Luzz M, Linas N, Cedeno N, Dunne M, Berman J, 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65 :90–93.
-
7
Dua VK, Kar PK, Sharma VP, 1996. Chloroquine resistant P. vivax malaria in India.Trop Med Int Health 1 :816–819.
-
8
Marlar Than, Myat Phone Kyaw, Aye Yu Soe, Khaing Khaing Gyi, Ma Sabai, Myint Oo, 1995. Development of resistance to chloroquine by P. vivax in Myanmar. Trans R Soc Trop Med Hyg 89 :307–308.
-
9
Simpson J, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ, 1999. Red cell selectivity in malaria: a study of multiple infected erythrocytes. Trans R Soc Trop Med Hyg 93 :165–168.
-
10
Silamut K, Hough R, Eggelte T, Pukrittayakamee S, Angus B, White NJ, 1995. A simple method for assessing quinine per-treatment in acute malaria. Trans R Soc Trop Med Hyg 89 :665–667.
-
11
Brockman A, Price R, van Vugt M, Heppner DG, Walsh D, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F, 2000. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunatemefloquine. Trans R Soc Trop Med Hyg 94 :537–544.
-
12
Fevre EM, Barnish G, Yamongul P, Rooney W, 1999. Sensitivity in vitro of Plasmodium falciparum to three currently used antimalarial drugs on the western border of Thailand. Trans R Soc Trop Med Hyg 93 :180–184.
-
13
Childs GE, Pang L, Wimonwattrawatee T, Pooyindee N, Nanakorn A, Limchitee S, Webster HK, 1987. In vitro mefloquine resistance of Plasmodium falciparum isolated from the Burmese border region of Thailand. Southeast Asian J Trop Med Public Health 18 :438–443.
-
14
Pukrittayakamee S, Chantra A, Simpson J, Vanijanonta S, Clemens R, Looareesuwan S, White NJ, 2000. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother 44 :1680–1685.
-
15
Chulay J, Watkins WM, Sixsmith DG, 1984. Synergistic antimalrial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.Am J Trop Med Hyg 33 :325–330.
-
16
Brockelman CR, Tan-Ariya P, 1982. Plasmodium falciparum in continuous culture: a new medium for the in vitro test for sulfadoxine sensitivity. Bull World Health Organ 60 :423–426.
-
17
Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H, 1995. Chloroquine resistance of Plasmodium falciparum: a biological advantage? Trans R Soc Trop Med Hyg 89 :90–91.
-
18
Tan-Ariya P, Na-Bangchang K, Tin T, Limpaibul L, Brockelman CR, Karbwang J, 1995. Clinical response and susceptibility in vitro of Plasmodim vivax to the standard regimen of chloroquine in Thailand. Trans R Soc Trop Med Hyg 89 :426–429.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 262 | 241 | 55 |
| Full Text Views | 270 | 3 | 1 |
| PDF Downloads | 60 | 3 | 1 |
IN VITRO EFFICACY OF ANTIMALARIAL DRUGS AGAINST PLASMODIUM VIVAX ON THE WESTERN BORDER OF THAILAND
KESINEE CHOTIVANICH
KESINEE CHOTIVANICH
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by KESINEE CHOTIVANICH in
Current site
Google Scholar
PubMed
Search for other papers by KESINEE CHOTIVANICH in
Current site
Google Scholar
PubMed
RACHANEE UDOMSANGPETCH
RACHANEE UDOMSANGPETCH
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by RACHANEE UDOMSANGPETCH in
Current site
Google Scholar
PubMed
Search for other papers by RACHANEE UDOMSANGPETCH in
Current site
Google Scholar
PubMed
WIRONGRONG CHIERAKUL
WIRONGRONG CHIERAKUL
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by WIRONGRONG CHIERAKUL in
Current site
Google Scholar
PubMed
Search for other papers by WIRONGRONG CHIERAKUL in
Current site
Google Scholar
PubMed
PAUL N. NEWTON
PAUL N. NEWTON
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by PAUL N. NEWTON in
Current site
Google Scholar
PubMed
Search for other papers by PAUL N. NEWTON in
Current site
Google Scholar
PubMed
RONATRAI RUANGVEERAYUTH
RONATRAI RUANGVEERAYUTH
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by RONATRAI RUANGVEERAYUTH in
Current site
Google Scholar
PubMed
Search for other papers by RONATRAI RUANGVEERAYUTH in
Current site
Google Scholar
PubMed
SASITHON PUKRITTAYAKAMEE
SASITHON PUKRITTAYAKAMEE
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by SASITHON PUKRITTAYAKAMEE in
Current site
Google Scholar
PubMed
Search for other papers by SASITHON PUKRITTAYAKAMEE in
Current site
Google Scholar
PubMed
SORNCHAI LOOAREESUWAN
SORNCHAI LOOAREESUWAN
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by SORNCHAI LOOAREESUWAN in
Current site
Google Scholar
PubMed
Search for other papers by SORNCHAI LOOAREESUWAN in
Current site
Google Scholar
PubMed
NICHOLAS J. WHITE
NICHOLAS J. WHITE
Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok. Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom; Mae Sot Hospital, Tak, Thailand
Search for other papers by NICHOLAS J. WHITE in
Current site
Google Scholar
PubMed
Search for other papers by NICHOLAS J. WHITE in
Current site
Google Scholar
PubMed
The susceptibility of 20 isolates of Plasmodium vivax on the Thailand-Myanmar border to seven antimalarial drugs was evaluated using the schizont maturation inhibition technique. The geometric mean 50% inhibition concentration (IC50) values were quinine = 308 ng/mL, amodiaquine =14 ng/mL, chloroquine =50 ng/mL, mefloquine = 127 ng/mL, sulfadoxine/pyrimethamine (80:1) = 800/10 ng/mL, pyrimethamine = 8 ng/mL, and artesunate = 0.5 ng/mL. Compared with P. falciparum in this area, P. vivax was more sensitive to chloroquine and artesunate, equally sensitive to quinine, and more resistant to mefloquine.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Kidson C, Singhasivanon P, Supavej S, 1999. Mekong Malaria. Southeast Asian J Trop Med Public Health 30 (suppl 4):28–40.
-
2
Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ, 1991. Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 85 :424–429.
-
3
Nosten F, McGready R, Simpson J, Thwai KL, Balkan S, Cho L, Hkirijareon L, Looareesuwan S, White NJ, 1999. Effects of Plasmodium vivax malaria in pregnanacy. Lancet 14 :546–549.
-
4
Schuurkamp G, Spicer PE, Kereu RK, Bulungol PK, 1992. Chloroquine resistant P. vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86 :121–122.
-
5
Baird JK, Basri, Purnomo, Bang MJ, Subbianto B, Patchen LC, Hoffmann SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44 :547–555.
-
6
Soto J, Toledo J, Gutierrz P, Luzz M, Linas N, Cedeno N, Dunne M, Berman J, 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65 :90–93.
-
7
Dua VK, Kar PK, Sharma VP, 1996. Chloroquine resistant P. vivax malaria in India.Trop Med Int Health 1 :816–819.
-
8
Marlar Than, Myat Phone Kyaw, Aye Yu Soe, Khaing Khaing Gyi, Ma Sabai, Myint Oo, 1995. Development of resistance to chloroquine by P. vivax in Myanmar. Trans R Soc Trop Med Hyg 89 :307–308.
-
9
Simpson J, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ, 1999. Red cell selectivity in malaria: a study of multiple infected erythrocytes. Trans R Soc Trop Med Hyg 93 :165–168.
-
10
Silamut K, Hough R, Eggelte T, Pukrittayakamee S, Angus B, White NJ, 1995. A simple method for assessing quinine per-treatment in acute malaria. Trans R Soc Trop Med Hyg 89 :665–667.
-
11
Brockman A, Price R, van Vugt M, Heppner DG, Walsh D, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F, 2000. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunatemefloquine. Trans R Soc Trop Med Hyg 94 :537–544.
-
12
Fevre EM, Barnish G, Yamongul P, Rooney W, 1999. Sensitivity in vitro of Plasmodium falciparum to three currently used antimalarial drugs on the western border of Thailand. Trans R Soc Trop Med Hyg 93 :180–184.
-
13
Childs GE, Pang L, Wimonwattrawatee T, Pooyindee N, Nanakorn A, Limchitee S, Webster HK, 1987. In vitro mefloquine resistance of Plasmodium falciparum isolated from the Burmese border region of Thailand. Southeast Asian J Trop Med Public Health 18 :438–443.
-
14
Pukrittayakamee S, Chantra A, Simpson J, Vanijanonta S, Clemens R, Looareesuwan S, White NJ, 2000. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother 44 :1680–1685.
-
15
Chulay J, Watkins WM, Sixsmith DG, 1984. Synergistic antimalrial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.Am J Trop Med Hyg 33 :325–330.
-
16
Brockelman CR, Tan-Ariya P, 1982. Plasmodium falciparum in continuous culture: a new medium for the in vitro test for sulfadoxine sensitivity. Bull World Health Organ 60 :423–426.
-
17
Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H, 1995. Chloroquine resistance of Plasmodium falciparum: a biological advantage? Trans R Soc Trop Med Hyg 89 :90–91.
-
18
Tan-Ariya P, Na-Bangchang K, Tin T, Limpaibul L, Brockelman CR, Karbwang J, 1995. Clinical response and susceptibility in vitro of Plasmodim vivax to the standard regimen of chloroquine in Thailand. Trans R Soc Trop Med Hyg 89 :426–429.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 262 | 241 | 55 |
| Full Text Views | 270 | 3 | 1 |
| PDF Downloads | 60 | 3 | 1 |